FH
Schedule 13G filing
FEDERATED HERMES, INC. disclosed a 5.1% stake in aTYR PHARMA INC (ATYR)
FEDERATED HERMES, INC. reported owning 5.1% of aTYR PHARMA INC (ATYR) (4,965,414 shares) in a Schedule 13G filed Oct 7, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
More ATYR insider and Congress trades
From a public Schedule 13G, linked above. Not investment advice, and not a recommendation to buy or sell.